These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11895457

  • 1. Serum angiogenin concentrations in young patients with diabetes mellitus.
    Chiarelli F, Pomilio M, Mohn A, Tumini S, Verrotti A, Mezzetti A, Cipollone F, Wasniewska M, Morgese G, Spagnoli A.
    Eur J Clin Invest; 2002 Feb; 32(2):110-4. PubMed ID: 11895457
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F, Spagnoli A, Basciani F, Tumini S, Mezzetti A, Cipollone F, Cuccurullo F, Morgese G, Verrotti A.
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [Abstract] [Full Text] [Related]

  • 3. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
    Chiarelli F, de Martino M, Mezzetti A, Catino M, Morgese G, Cuccurullo F, Verrotti A.
    J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
    [Abstract] [Full Text] [Related]

  • 4. Angiogenin in middle-aged type 1 diabetes patients.
    Neubauer-Geryk J, Kozera GM, Wolnik B, Szczyrba S, Nyka WM, Bieniaszewski L.
    Microvasc Res; 2012 Nov; 84(3):387-9. PubMed ID: 22940420
    [Abstract] [Full Text] [Related]

  • 5. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F, Catino M, Tumini S, Cipollone F, Mezzetti A, Vanelli M, Verrotti A.
    Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
    [Abstract] [Full Text] [Related]

  • 6. Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus.
    Malamitsi-Puchner A, Sarandakou A, Dafogianni C, Tziotis J, Bartsocas CS.
    Pediatr Res; 1998 Jun; 43(6):798-800. PubMed ID: 9621990
    [Abstract] [Full Text] [Related]

  • 7. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
    Öberg D, Salemyr J, Örtqvist E, Juul A, Bang P.
    Pediatr Diabetes; 2018 Aug; 19(5):972-978. PubMed ID: 29663652
    [Abstract] [Full Text] [Related]

  • 8. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy.
    Marek N, Raczyńska K, Siebert J, Myśliwiec M, Zorena K, Myśliwska J, Reiwer-Gostomska M, Trzonkowski P.
    Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846
    [Abstract] [Full Text] [Related]

  • 9. Glycemic control influences serum angiogenin concentrations in patients with type 2 diabetes.
    Siebert J, Reiwer-Gostomska M, Mysliwska J, Marek N, Raczynska K, Glasner L.
    Diabetes Care; 2010 Aug; 33(8):1829-30. PubMed ID: 20484129
    [Abstract] [Full Text] [Related]

  • 10. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
    Willems D, Dorchy H, Dufrasne D.
    Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
    [Abstract] [Full Text] [Related]

  • 11. Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.
    Chiarelli F, Pomilio M, Mohn A, Tumini S, Vanelli M, Morgese G, Spagnoli A, Verrotti A.
    J Pediatr; 2000 Sep; 137(3):386-92. PubMed ID: 10969265
    [Abstract] [Full Text] [Related]

  • 12. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
    Nordwall M, Abrahamsson M, Dhir M, Fredrikson M, Ludvigsson J, Arnqvist HJ.
    Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
    [Abstract] [Full Text] [Related]

  • 13. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H.
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [Abstract] [Full Text] [Related]

  • 14. Adiponectin as a marker of complications in type I diabetes.
    Habeeb NM, Youssef OI, Saab AA, El Hadidi ES.
    Indian Pediatr; 2012 Apr; 49(4):277-80. PubMed ID: 21992860
    [Abstract] [Full Text] [Related]

  • 15. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.
    Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J.
    BMJ; 2019 Aug 28; 366():l4894. PubMed ID: 31462492
    [Abstract] [Full Text] [Related]

  • 16. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.
    Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB, Danish Study Group of Diabetes in Childhood.
    J Diabetes Complications; 2004 Aug 28; 18(3):160-4. PubMed ID: 15145327
    [Abstract] [Full Text] [Related]

  • 17. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL, Bessmertnaya EG, Shestakova MV, Shamkhalova MS, Nikankina LV, Ilyin AV, Glek IS, Zolotukhin AV, Dedov II.
    Ter Arkh; 2017 Aug 28; 89(10):17-21. PubMed ID: 29171465
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the vascular endothelial growth factor in children and adolescents with type 1 diabetes].
    Peczyńska J, Urban M, Urban B, Głowińska B.
    Pol Merkur Lekarski; 2004 May 28; 16(95):438-42. PubMed ID: 15518422
    [Abstract] [Full Text] [Related]

  • 19. High serum leptin levels in children with type 1 diabetes mellitus: contribution of age, BMI, pubertal development and metabolic status.
    Luna R, Garcia-Mayor RV, Lage M, Andrade MA, Barreiro J, Pombo M, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1999 Nov 28; 51(5):603-10. PubMed ID: 10594521
    [Abstract] [Full Text] [Related]

  • 20. Early signs of microvascular complications in pediatric patients with short duration of type 1 diabetes mellitus seen in southeast Nigeria.
    Ogugua CF, Chikani UN, Ibekwe MU, Ngwieri T, Allen H.
    Ann Afr Med; 2019 Nov 28; 18(4):200-205. PubMed ID: 31823955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.